Startling stat: 2.8 million antibiotic resistance infections occur in the U.S. each year—resulting in more than 35,000 deaths.
More stats + what's needed to turn the tide: https://t.co/dBFdN1QymC
Antibiotics use in livestock production is one of the many reasons for the spread of AMR but we can celebrate that WOAH's report on antimicrobials use in animals https://t.co/tie0YHrfAx found a 13%⬇️in the amount of antimicrobials used in animals from 2017-19 and 68% of countries
Infectious disease experts are pressing Congress to commit $6 billion to incentivize the production of new treatments for drug-resistant infections as lawmakers take up broader pandemic preparedness legislation.
https://t.co/c3X76bip5Z
In recent months, national and global health officials have issued dire warnings about the dangers of drug-resistant infections, a number of which have spread throughout New Jersey.
https://t.co/zpRu6OQwJV
"We are now having to go back and use old #antibiotics as last resort options—or using other drugs that have toxicity concerns—as none of our other drugs are working to fight these infections." –@JeremyJBarr https://t.co/CM52wV1Rui
AMR was, directly and indirectly, responsible for an estimated five million or so deaths in 2019. By 2050, up to 10 million deaths could occur annually – on par with the 2020 rate of cancer deaths.
https://t.co/GzjDyS1pkC
RT @CDC_AR#AntibioticResistance is still a significant public health threat in the United States. Remember: #antibiotics do not work on viral infections, including #COVID19. Do you need that antibiotic? https://t.co/yXYmKw2NkK
#AMR
Amazing presentation by @e_charani on Antimicrobial shortages. What is the role of pharma and governments? Supply chain ambiguity, collateral damage of shortages on access and #AMR, what can we learn from HIV/TB and financial incentives and automation? Role of #ASP? #ECCMID2023
A major new UN report says we’ve ignored the role of environmental degradation in fueling the superbugs that kill 1.27 million people each year.
https://t.co/FE4zSJAjpU
A bipartisan bill awaiting congressional action would spur much-needed investment in antibiotic development and enjoys rare mutual support from patients, doctors and the biopharmaceutical industry.
https://t.co/Jcfd5zqKmC